NEW YORK, NY – March 16, 2021 – International Pharmaceutical Expo (INTERPHEX), the premier event dedicated to pharmaceutical, biotechnology and device innovation, technology and knowledge from development through commercialization, are pleased to announced Douglas Lugo has joined the team as the new Event Director. INTERPHEX takes place October 19-21, 2021 at the Javits Center in New York, New York.
Douglas, a twenty (20) year tradeshow industry veteran has lead multiple global portfolios most recently with Informa. “It’s a great honor to join Reed Exhibitions and contribute to such an important event. The pharmaceutical industry is taking the lead to expedite the end to the global pandemic and INTERPHEX is now more relevant than ever before. I’m excited to be a part of this community of elite professionals”
Stay tuned for more announcements around our new reloaded RECONNEX 365, your year-round digital sourcing solution for pharmaceutical, biotechnology and device development and manufacturing industry. RECONNEX 365 is your source for product discovery, connecting with new customers, learning from industry thought leadership; including case studies, new technologies, expert insight, articles, webinars, news updates, videos and interviews. Exhibitors of INTERPHEX, representing the full product development lifecycle, will digitally debut new and existing technical content, technologies and solutions designed to accelerate time to market. Attendees will be able to year-round investigate cutting-edge technologies, exchange knowledge and schedule 1 on 1 meetings directly with exhibitors to procure the products, technologies and services they need.
At INTERPHEX and all Reed Exhibitions events, your health and safety is our top priority. As part of this commitment, we’ve taken proactive steps and implemented new guidelines and policies to help support a safe experience. For more information please review our Health and Safety page here.
Pre-registration for INTERPHEX 2021 is open and key industry professionals, are invited to pre-register and experience everything INTERPHEX has to offer.
For 42 years, INTERPHEX has been, and continues to be, the premier pharmaceutical, biotechnology, and device development and manufacturing event where you can “Experience Science through Commercialization.” Sponsored by the Parenteral Drug Association (PDA), the event is based in New York and brings over 10,000 global industry professionals and 625+ industry leading suppliers together to “Learn it, Experience it, Procure it” through a unique combination of exhibits, demonstrations, partnering opportunities, networking and no cost technical conference to leverage quality, efficiency and cost effectiveness in today’s ever-changing global market. INTERPHEX offers annual domestic and international industry events and educational opportunities around the world. INTERPHEX and INNOPHEX together, offer the very latest intelligence, cutting-edge technologies and state-of-the-art innovation throughout the product development life cycle. Follow INTERPHEX on Facebook, LinkedIn, Instagram, YouTube, and Twitter. continues the learning beyond the show floor. For more information, visit www.INTERPHEX.com.
About Reed Exhibitions Global
Reed Exhibitions is a leading global events business. It combines face-to-face with data and digital tools to help customers learn about markets, source products and complete transactions at over 400 events in 22 countries across 43 industry sectors, attracting more than 7 million participants. Our events leverage industry expertise, large data sets and technology to enable our customers to connect face-to-face or digitally and generate billions of dollars of revenues for the economic development of local markets and national economies around the world. Reed Exhibitions is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers.www.reedexhibitions.com
RELX is a global provider of information-based analytics and decision tools for professional and business customers. The Group serves customers in more than 180 countries and has offices in about 40 countries. It employs over 33,000 people, of whom almost half are in North America. The shares of RELX PLC, the parent company, are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RELX. The market capitalisation is approximately £33bn, €39bn, $47bn.*
*Note: Current market capitalisation can be found at http://www.relx.com/investors